Skip to main content
Top
Published in: Skeletal Radiology 2/2019

01-02-2019 | Case Report

Progression of dialysis-related amyloidoma towards pathologic fracture

Authors: Joe D. Baal, Andrew E. Horvai, Thomas M. Link

Published in: Skeletal Radiology | Issue 2/2019

Login to get access

Abstract

Amyloidosis is the extracellular deposition of amyloid protein fibrils, and this condition may be hereditary or acquired. Patients undergoing long-term hemodialysis are particularly at risk for developing acquired amyloidosis. A rare form of amyloidosis is an amyloidoma or amyloid tumor, which occurs when amyloid focally deposits in a section of the musculoskeletal system, most commonly in the osteoarticular system. Here, we present a case of a hemodialysis-related amyloidoma of the left femoral neck in an 80-year-old woman with end-stage renal disease on hemodialysis for 8 years. The purpose of this report is to provide an account of the unique clinical, imaging, and histopathologic manifestation of a dialysis-related amyloidoma that progressively enlarges over a 2-year period. This report also highlights some prophylactic measures that may reduce the risk of developing an associated pathologic fracture.
Literature
1.
go back to reference Ross LV, Ross GJ, Mesgarzadeh M, Edmonds PR, Bonakdarpour A. Hemodialysis-related amyloidomas of bone. Radiology. 1991;178(1):263–5.CrossRef Ross LV, Ross GJ, Mesgarzadeh M, Edmonds PR, Bonakdarpour A. Hemodialysis-related amyloidomas of bone. Radiology. 1991;178(1):263–5.CrossRef
2.
go back to reference Kuntz D, Naveau B, Bardin T, Drueke T, Treves R, Dryll A. Destructive spondyloarthropathy in hemodialyzed patients. A new syndrome. Arthritis Rheum. 1984;27(4):369–75.CrossRef Kuntz D, Naveau B, Bardin T, Drueke T, Treves R, Dryll A. Destructive spondyloarthropathy in hemodialyzed patients. A new syndrome. Arthritis Rheum. 1984;27(4):369–75.CrossRef
3.
go back to reference Danesh F, Ho LT. Dialysis-related amyloidosis: history and clinical manifestations. Semin Dial. 2001;14(2):80–5.CrossRef Danesh F, Ho LT. Dialysis-related amyloidosis: history and clinical manifestations. Semin Dial. 2001;14(2):80–5.CrossRef
4.
go back to reference Floege J. Ketteler M. beta2-microglobulin-derived amyloidosis: an update. Kidney Int Suppl. 2001;78:S164–71.CrossRef Floege J. Ketteler M. beta2-microglobulin-derived amyloidosis: an update. Kidney Int Suppl. 2001;78:S164–71.CrossRef
5.
go back to reference Kiss E, Keusch G, Zanetti M, et al. Dialysis-related amyloidosis revisited. AJR Am J Roentgenol. 2005;185(6):1460–7.CrossRef Kiss E, Keusch G, Zanetti M, et al. Dialysis-related amyloidosis revisited. AJR Am J Roentgenol. 2005;185(6):1460–7.CrossRef
6.
go back to reference Alshehri F. Hemodialysis-induced amyloid arthropathy of hip presenting as pathological fracture—a case report and literature review. J Clin Diagn Res. 2014;8(10):RD01–2.PubMedPubMedCentral Alshehri F. Hemodialysis-induced amyloid arthropathy of hip presenting as pathological fracture—a case report and literature review. J Clin Diagn Res. 2014;8(10):RD01–2.PubMedPubMedCentral
7.
go back to reference Casey TT, Stone WJ, Diraimondo CR, et al. Tumoral amyloidosis of bone of beta 2-microglobulin origin in association with long-term hemodialysis: a new type of amyloid disease. Hum Pathol. 1986;17(7):731–8.CrossRef Casey TT, Stone WJ, Diraimondo CR, et al. Tumoral amyloidosis of bone of beta 2-microglobulin origin in association with long-term hemodialysis: a new type of amyloid disease. Hum Pathol. 1986;17(7):731–8.CrossRef
8.
go back to reference Giorgetti S, Rossi A, Mangione P, et al. Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. Protein Sci. 2005;14(3):696–702.CrossRef Giorgetti S, Rossi A, Mangione P, et al. Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. Protein Sci. 2005;14(3):696–702.CrossRef
9.
go back to reference Jadoul M, Garbar C, Noël H, et al. Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study. Kidney Int. 1997;51(6):1928–32.CrossRef Jadoul M, Garbar C, Noël H, et al. Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study. Kidney Int. 1997;51(6):1928–32.CrossRef
10.
go back to reference Hipp JA, Springfield DS, Hayes WC. Predicting pathologic fracture risk in the management of metastatic bone defects. Clin Orthop Relat Res. 1995;312:120–35. Hipp JA, Springfield DS, Hayes WC. Predicting pathologic fracture risk in the management of metastatic bone defects. Clin Orthop Relat Res. 1995;312:120–35.
11.
go back to reference Piccioli A, Spinelli MS, Maccauro G. Impending fracture: a difficult diagnosis. Injury. 2014;45(Suppl 6):S138–41.CrossRef Piccioli A, Spinelli MS, Maccauro G. Impending fracture: a difficult diagnosis. Injury. 2014;45(Suppl 6):S138–41.CrossRef
12.
go back to reference Jawad MU, Scully SP. In brief: classifications in brief: Mirels' classification: metastatic disease in long bones and impending pathologic fracture. Clin Orthop Relat Res. 2010;468(10):2825–7.CrossRef Jawad MU, Scully SP. In brief: classifications in brief: Mirels' classification: metastatic disease in long bones and impending pathologic fracture. Clin Orthop Relat Res. 2010;468(10):2825–7.CrossRef
13.
go back to reference Kreul SM, Sorger JI, Rajamanickam VP, Heiner JP. Updated outcomes of prophylactic femoral fixation. Orthopedics. 2016;39(2):e346–52.CrossRef Kreul SM, Sorger JI, Rajamanickam VP, Heiner JP. Updated outcomes of prophylactic femoral fixation. Orthopedics. 2016;39(2):e346–52.CrossRef
14.
go back to reference Lin JS, Santiago-torres JE, Everhart JS, Zayan NE, Mayerson JL, Scharschmidt TJ. When is hemiarthroplasty preferable to intramedullary prophylactic fixation of malignant lesions of the proximal femur? J Surg Oncol. 2017;116(8):1132–40.CrossRef Lin JS, Santiago-torres JE, Everhart JS, Zayan NE, Mayerson JL, Scharschmidt TJ. When is hemiarthroplasty preferable to intramedullary prophylactic fixation of malignant lesions of the proximal femur? J Surg Oncol. 2017;116(8):1132–40.CrossRef
15.
go back to reference Hartmann J, Fricke H, Schiffl H. Biocompatible membranes preserve residual renal function in patients undergoing regular hemodialysis. Am J Kidney Dis. 1997;30(3):366–73.CrossRef Hartmann J, Fricke H, Schiffl H. Biocompatible membranes preserve residual renal function in patients undergoing regular hemodialysis. Am J Kidney Dis. 1997;30(3):366–73.CrossRef
16.
go back to reference Scarpioni R, Ricardi M, Albertazzi V, De Amicis S, Rastelli F, Zerbini L. Dialysis-related amyloidosis: challenges and solutions. Int J Nephrol Renov Dis. 2016;9:319–28.CrossRef Scarpioni R, Ricardi M, Albertazzi V, De Amicis S, Rastelli F, Zerbini L. Dialysis-related amyloidosis: challenges and solutions. Int J Nephrol Renov Dis. 2016;9:319–28.CrossRef
17.
go back to reference Tan SY, Pepys MB, Hawkins PN. Treatment of amyloidosis. Am J Kidney Dis. 1995;26(2):267–85.CrossRef Tan SY, Pepys MB, Hawkins PN. Treatment of amyloidosis. Am J Kidney Dis. 1995;26(2):267–85.CrossRef
Metadata
Title
Progression of dialysis-related amyloidoma towards pathologic fracture
Authors
Joe D. Baal
Andrew E. Horvai
Thomas M. Link
Publication date
01-02-2019
Publisher
Springer Berlin Heidelberg
Published in
Skeletal Radiology / Issue 2/2019
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-018-3009-2

Other articles of this Issue 2/2019

Skeletal Radiology 2/2019 Go to the issue